High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
about
Treatment of pituitary carcinomas and atypical pituitary adenomas: a reviewTemozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment.The expression profile of Dopamine D2 receptor, MGMT and VEGF in different histological subtypes of pituitary adenomas: a study of 197 cases and indications for the medical therapyTemozolomide Therapy for Aggressive Pituitary Tumors: Results in a Small Series of Patients from Argentina.Expression profiling of O(6) methylguanine-DNA-methyl transferase in prolactinomas: a correlative study of promoter methylation and pathological features in 136 cases.O-6-Methylguanine-DNA methyltransferase expression is associated with pituitary adenoma tumor recurrence: a systematic meta-analysisTreatment of pituitary neoplasms with temozolomide: a review.Temozolomide for corticotroph pituitary adenomas refractory to standard therapy.Therapy of aggressive pituitary tumors.Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature.Temozolomide in the management of dopamine agonist-resistant prolactinomas.Temozolomide in aggressive pituitary adenomas and carcinomas.Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide.Molecular basis of pharmacological therapy in Cushing's disease.Current status on histological classification in Cushing's disease.Crooke's cell tumors of the pituitary.Temozolomide-Induced Shrinkage of Invasive Pituitary Adenoma in Patient with Nelson's Syndrome: A Case Report and Review of the Literature.Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reportsIncreased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology.Chemotherapy-induced regression of an adrenocorticotropin-secreting pituitary carcinoma accompanied by secondary adrenal insufficiency.A case of nonfunctioning pituitary carcinoma that responded to temozolomide treatment.MGMT immunoexpression in adamantinomatous craniopharyngiomas.MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas.MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals.MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas.O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas.Recent advances in understanding corticotroph pituitary tumor initiation and progression
P2860
Q30872897-1A4EA30D-3CDF-4033-A0D3-9A4C45A48E29Q33427688-3621AF9C-7B80-4D87-9984-32D31EFF8A42Q34467881-D2D22892-713C-4210-8C2E-AC62EE4340FAQ35708559-41845281-A25A-43CA-974F-326F1B0A4584Q35785924-1A7D1FFB-0F4A-4E69-823E-D4F5AF67D3B1Q36268061-7A02BD17-E20A-4D26-B383-6C406EE47A8FQ37789267-20D3DBE8-2427-4798-8138-4AD52E96C1CAQ37802798-0CAD592B-7C80-487E-993D-3AEB4CF64D51Q37857296-B825C348-0BF6-4F3D-B2DA-181FD752661DQ37865580-6649F5CA-C749-4AC9-8D2E-4627851C7B13Q37955091-F664B487-CC90-45AF-9E2E-EC7526F6C3CBQ37988909-FFB84AD8-97E7-407C-A7C2-4386BAA5749BQ38010032-4807E676-9781-4F07-AFC4-B58D889AFDE2Q38129776-32BA32C8-E3E6-4CE8-9AD0-2F64DAB098F3Q38165863-4B149FD6-0041-48FC-89DD-4018C61049E2Q38287030-348B570A-FF86-4714-A0C4-8C4718A77B05Q38337671-87E95DCF-3DBD-4345-B9A2-88DFEF418FA3Q38556703-227ED911-9AC0-4C62-85E3-D3889602AADCQ38934576-3CDD2DA1-A5A3-493D-9479-A94C0E0C65DDQ40999806-65AB54C0-B7F3-4227-BED3-77911796CCA2Q41817909-406F70E3-0289-4BED-84C9-9D619E04F3DBQ42002190-C097F2AE-1926-4CED-8F02-9EF92F052D6AQ44751918-4F1FA436-EC24-4408-9FAF-DA3618A8C388Q47161911-DAAF7C5D-2D71-465A-90F4-5CFA8878E498Q49979233-32197936-AA79-4996-A0F1-97C0E9625D5DQ51604204-C6EFF9AB-0733-4AD4-AD44-B3BABDC2D22CQ55462926-D4CA33BF-5D3E-4B37-8194-F7D0B62E16ADQ58694608-FABCF741-9CC7-4332-B6B9-8F4401960623
P2860
High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
High incidence of low O
@nl
High incidence of low O(6)-met ...... adenomas of Cushing's disease.
@en
type
label
High incidence of low O
@nl
High incidence of low O(6)-met ...... adenomas of Cushing's disease.
@en
prefLabel
High incidence of low O
@nl
High incidence of low O(6)-met ...... adenomas of Cushing's disease.
@en
P2093
P356
P1476
High incidence of low O(6)-met ...... adenomas of Cushing's disease.
@en
P2093
Akira Takeshita
Chikao Okuda
Kenichi Ohashi
Kenichi Oyama
Manabu Taguchi
Naoko Inoshita
Noriaki Fukuhara
Shozo Yamada
Toshiaki Sano
Yasuhiro Takeuchi
P304
P356
10.1530/EJE-09-0414
P577
2009-07-09T00:00:00Z